NYSE ARCA | ETF
The fund will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents as well as in securities not included in the index, but which BFA believes will help the fund track the index.
It is non-diversified.
Top 20 Holdings
Asset | Name | Sector | Industry | Weight |
---|---|---|---|---|
ACAD | ACADIA Pharmaceuticals Inc | Healthcare | Biotechnology | 5.62% |
CPRX | Catalyst Pharmaceuticals Inc | Healthcare | Biotechnology | 5.09% |
NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.97% |
ARGX | argenx NV ADR | Healthcare | Biotechnology | 4.91% |
326030 | Sk Biopharmaceuticals Co Ltd | Healthcare | Biotechnology | 4.58% |
ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 4.40% |
PTCT | PTC Therapeutics Inc | Healthcare | Biotechnology | 4.33% |
KRTX | Karuna Therapeutics Inc | Healthcare | Biotechnology | 4.29% |
ALKS | Alkermes Plc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.09% |
CERE | Cerevel Therapeutics Holdings Inc | Healthcare | Biotechnology | 4.05% |
BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 3.93% |
SUPN | Supernus Pharmaceuticals Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.92% |
SRRK | Scholar Rock Holding Corp | Healthcare | Biotechnology | 3.86% |
XENE | Xenon Pharmaceuticals Inc | Healthcare | Biotechnology | 3.78% |
DNLI | Denali Therapeutics Inc | Healthcare | Biotechnology | 3.75% |
AXNX | Axonics Modulation Technologies Inc | Healthcare | Medical Devices | 3.69% |
LBPH | Longboard Pharmaceuticals Inc | Healthcare | Biotechnology | 3.66% |
HLUN-B | H Lundbeck A/S | Healthcare | Drug Manufacturers - Specialty & Generic | 3.03% |
NEU | Neuren Pharmaceuticals Ltd | Healthcare | Biotechnology | 2.89% |
4592 | Sanbio Company Limited | Healthcare | Biotechnology | 2.81% |